Journal article · 2025 · Open access

Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond.

Chongming Jiang, Yulun Chiu, Cassian Yee, Cheng‐Chi Chao, Xiling Shen

Journal of Clinical Oncology, 43(16_suppl), 2588 · Published 28 May 2025 · DOI 10.1200/jco.2025.43.16_suppl.2588

Open PDFView at the publisherCite this paper

In brief

“Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond.” is a 2025 journal article by Chongming Jiang and 4 co-authors, published in Journal of Clinical Oncology. OpenAlex counts 0 citations as of 18 November 2026. It is open access: the full text is free to read at Journal of Clinical Oncology.

Citations
0
Authors
5

Abstract

2588 Background: Recognition of peptides presented by the major histocompatibility complex (MHC) through the T cell receptor (TCR-pMHC) is crucial for T cell function, influencing disease conditions such as cancer, infections, and autoimmune disorders. Despite previous attempts, predictive models of TCR-pMHC specificity remain challenging. Methods: Inspired by recent breakthroughs in protein structure prediction achieved by deep neural networks, we explored structural modeling using AlphaFold 3 (AF3)-based AI-enabled computation as a potential avenue for predicting TCR epitope specificity. Results: We show that a specialized version of the neural network predictor AlphaFold can generate models of TCR-pMHC interactions, effectively distinguishing valid peptide epitopes from invalid ones with increasing accuracy. Strongly immunogenic epitopes could be identified and selected for vaccine development through in-silico high-throughput processes. Higher-affinity and specificity T cells could also be computationally designed to achieve improved efficacy and safety profiles for T cell therapy. An accurate TCR-pMHC prediction model is expected to significantly benefit T-cell-mediated immunotherapy and facilitate advanced drug design. Conclusions: Overall, precise prediction of T-cell immunogenicity holds substantial therapeutic potential, enabling the identification of peptide epitopes associated with tumors, infectious agents, and autoimmune diseases. Although much work remains before these predictions could achieve widespread practical utility, deep learning-based structural modeling represents a promising path toward the generalizable predictions of TCR-pMHC interactions and beyond.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Jiang, C., Chiu, Y., Yee, C., Chao, C., & Shen, X. (2025). Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond. Journal of Clinical Oncology, 43(16_suppl), 2588. https://doi.org/10.1200/jco.2025.43.16_suppl.2588

MLA 9

Jiang, Chongming, et al. “Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond.” Journal of Clinical Oncology, vol. 43, no. 16_suppl, 2025, p. 2588. https://doi.org/10.1200/jco.2025.43.16_suppl.2588.

Chicago

Jiang, Chongming, Yulun Chiu, Cassian Yee, Cheng‐Chi Chao, and Xiling Shen. 2025. “Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond.” Journal of Clinical Oncology 43 (16_suppl): 2588. https://doi.org/10.1200/jco.2025.43.16_suppl.2588.

Harvard

Jiang, C. et al. (2025) ‘Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond.’, Journal of Clinical Oncology, 43(16_suppl), p. 2588. doi:10.1200/jco.2025.43.16_suppl.2588.

IEEE

C. Jiang, Y. Chiu, C. Yee, C. Chao, and X. Shen, “Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond.,” Journal of Clinical Oncology, vol. 43, no. 16_suppl, p. 2588, 2025, doi: 10.1200/jco.2025.43.16_suppl.2588.

BibTeX

@article{jiang2025machine,
  title     = {{Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond.}},
  author    = {Jiang, Chongming and Chiu, Yulun and Yee, Cassian and Chao, Cheng‐Chi and Shen, Xiling},
  journal   = {Journal of Clinical Oncology},
  year      = {2025},
  volume    = {43},
  number    = {16_suppl},
  pages     = {2588},
  doi       = {10.1200/jco.2025.43.16_suppl.2588},
  url       = {https://doi.org/10.1200/jco.2025.43.16_suppl.2588}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches

  • T-cell epitope prediction
  • AlphaFold3
  • vaccine design
  • T cell therapy
  • cancer immunotherapy
  • autoimmune disease
  • infectious diseases

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Jiang, C., Chiu, Y., Yee, C., Chao, C., & Shen, X. (2025). Machine learning–driven approaches for predicting T-cell–mediated immunity and beyond. Journal of Clinical Oncology, 43(16_suppl), 2588. https://doi.org/10.1200/jco.2025.43.16_suppl.2588

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Clinical Oncology: sign in and open the PDF from this page.

Who wrote this paper?

Chongming Jiang, Yulun Chiu, Cassian Yee, Cheng‐Chi Chao, Xiling Shen.

What is the DOI of this paper?

10.1200/jco.2025.43.16_suppl.2588, permanently at https://doi.org/10.1200/jco.2025.43.16_suppl.2588. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.